8.54
price down icon0.12%   -0.01
 
loading
Schlusskurs vom Vortag:
$8.55
Offen:
$8.55
24-Stunden-Volumen:
755.34K
Relative Volume:
0.20
Marktkapitalisierung:
$801.08M
Einnahmen:
$324.00K
Nettoeinkommen (Verlust:
$-82.10M
KGV:
-9.1828
EPS:
-0.93
Netto-Cashflow:
$-69.18M
1W Leistung:
+0.00%
1M Leistung:
+0.47%
6M Leistung:
+870.45%
1J Leistung:
+865.63%
1-Tages-Spanne:
Value
$8.54
$8.55
1-Wochen-Bereich:
Value
$8.53
$8.55
52-Wochen-Spanne:
Value
$0.75
$8.55

Chimerix Inc Stock (CMRX) Company Profile

Name
Firmenname
Chimerix Inc
Name
Telefon
919.806.1074
Name
Adresse
2505 MERIDIAN PARKWAY, SUITE 100, DURHAM, NC
Name
Mitarbeiter
81
Name
Twitter
@chimerix
Name
Nächster Verdiensttermin
2025-03-21
Name
Neueste SEC-Einreichungen
Name
CMRX's Discussions on Twitter

Vergleichen Sie CMRX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CMRX
Chimerix Inc
8.54 801.08M 324.00K -82.10M -69.18M -0.93
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.52 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.49 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
595.70 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.75 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
229.22 26.16B 3.81B -644.79M -669.77M -6.24

Chimerix Inc Stock (CMRX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-05-23 Eingeleitet Robert W. Baird Outperform
2022-09-07 Eingeleitet CapitalOne Overweight
2021-04-29 Eingeleitet Maxim Group Buy
2021-04-23 Fortgesetzt Cowen Outperform
2021-03-31 Eingeleitet Jefferies Buy
2021-03-31 Eingeleitet Wedbush Outperform
2018-02-14 Herabstufung JP Morgan Neutral → Underweight
2018-02-02 Eingeleitet H.C. Wainwright Buy
2016-08-09 Bestätigt FBR Capital Mkt Perform
2016-02-23 Herabstufung Barclays Overweight → Equal Weight
2016-02-23 Bestätigt FBR Capital Mkt Perform
2016-02-23 Herabstufung Morgan Stanley Equal-Weight → Underweight
2016-02-22 Herabstufung Citigroup Buy → Neutral
2015-12-29 Herabstufung JP Morgan Overweight → Neutral
2015-12-28 Herabstufung FBR Capital Outperform → Mkt Perform
2015-12-28 Bestätigt Piper Jaffray Overweight
2015-12-17 Eingeleitet UBS Buy
2015-10-05 Herabstufung Morgan Stanley Overweight → Equal-Weight
2015-09-03 Eingeleitet Citigroup Buy
2015-08-18 Eingeleitet FBR Capital Outperform
2015-08-06 Bestätigt Brean Capital Buy
2015-05-11 Bestätigt Brean Capital Buy
2015-03-04 Eingeleitet Barclays Overweight
2015-02-12 Bestätigt Stifel Buy
2014-12-31 Bestätigt Brean Capital Buy
2014-07-08 Fortgesetzt Brean Capital Buy
Alle ansehen

Chimerix Inc Aktie (CMRX) Neueste Nachrichten

pulisher
04:30 AM

Jazz Pharmaceuticals Completes Acquisition of Chimerix - TipRanks

04:30 AM
pulisher
04:18 AM

Jazz Pharmaceuticals acquires Chimerix for $935 million - Investing.com

04:18 AM
pulisher
Apr 10, 2025

Chimerix stock soars to 52-week high, hits $8.54 By Investing.com - Investing.com South Africa

Apr 10, 2025
pulisher
Apr 10, 2025

Chimerix stock soars to 52-week high, hits $8.54 - Investing.com

Apr 10, 2025
pulisher
Apr 07, 2025

Unlocking Investment Potential Discover the Power of Magical Signals Bullish Signal - AInvest

Apr 07, 2025
pulisher
Apr 07, 2025

Top 3 Health Care Stocks That May Crash In Q2 - Benzinga

Apr 07, 2025
pulisher
Apr 02, 2025

Chimerix stock soars to 52-week high, hits $8.53 By Investing.com - Investing.com Australia

Apr 02, 2025
pulisher
Apr 02, 2025

Chimerix stock soars to 52-week high, hits $8.53 - Investing.com

Apr 02, 2025
pulisher
Apr 01, 2025

Jazz Pharmaceuticals, Chimerix HSR waiting period expired on March 31 - MLex

Apr 01, 2025
pulisher
Apr 01, 2025

Is Chimerix Inc. (CMRX) the Best Performing NASDAQ Stock So Far in 2025? - Insider Monkey

Apr 01, 2025
pulisher
Mar 31, 2025

11 Best Performing NASDAQ Stocks So Far in 2025 - Insider Monkey

Mar 31, 2025
pulisher
Mar 31, 2025

Exploring US High Growth Tech Stocks In March 2025 - simplywall.st

Mar 31, 2025
pulisher
Mar 26, 2025

Chimerix Inc. (NASDAQ:CMRX) Amazing Performance So Far In 2025 - Yahoo Finance

Mar 26, 2025
pulisher
Mar 24, 2025

11 Best Performing Stocks So Far In 2025 - Insider Monkey

Mar 24, 2025
pulisher
Mar 24, 2025

Chimerix Reports 2024 Losses Amid Acquisition News - TipRanks

Mar 24, 2025
pulisher
Mar 21, 2025

Chimerix earnings missed, revenue fell short of estimates By Investing.com - Investing.com Canada

Mar 21, 2025
pulisher
Mar 21, 2025

Chimerix Inc Reports Q4 2024 EPS of -$0.25, Beating Estimates; R - GuruFocus.com

Mar 21, 2025
pulisher
Mar 21, 2025

The buildup to Chimerix's $935M exit to Jazz, with more than half a dozen parties intrigued - Endpoints News

Mar 21, 2025
pulisher
Mar 21, 2025

Chimerix: Q4 Earnings Snapshot - mySA

Mar 21, 2025
pulisher
Mar 21, 2025

Chimerix Inc. (CMRX) reports earnings - Quartz

Mar 21, 2025
pulisher
Mar 21, 2025

CHIMERIX INC SEC 10-K Report - TradingView

Mar 21, 2025
pulisher
Mar 21, 2025

Chimerix Reports Fourth Quarter and Year End 2024 Financial Results - The Manila Times

Mar 21, 2025
pulisher
Mar 21, 2025

Chimerix Reports Earnings as $935M Jazz Buyout and FDA Drug Review Advance - StockTitan

Mar 21, 2025
pulisher
Mar 20, 2025

Investment Analysts’ Recent Ratings Updates for Chimerix (CMRX) - Defense World

Mar 20, 2025
pulisher
Mar 13, 2025

Chimerix stock soars to 52-week high, hits $8.47 By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

Chimerix stock soars to 52-week high, hits $8.47 - Investing.com India

Mar 13, 2025
pulisher
Mar 13, 2025

Ireland: Jazz adds to oncology pipeline with Chimerix - Investors in Healthcare

Mar 13, 2025
pulisher
Mar 12, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RDFN, BLBX, CMRX, WBA on Behalf of Shareholders - GlobeNewswire Inc.

Mar 12, 2025
pulisher
Mar 11, 2025

Kuehn Law Encourages BRDG, CMRX, WBA and SYTA Investors to Contact Law Firm - The Malaysian Reserve

Mar 11, 2025
pulisher
Mar 11, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Mar 11, 2025
pulisher
Mar 11, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 2seventy bio, Inc. (NasdaqTSVT), Bridge Investment Group Holdings Inc. (NYSEBRDG), Chimerix, Inc. (NasdaqCMRX), 180 Degree Capital Corp. (Nasda - Morningstar

Mar 11, 2025
pulisher
Mar 11, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CMRX, WBA, BLUE on Behalf of Shareholders - Victoria Advocate

Mar 11, 2025
pulisher
Mar 10, 2025

CHIMERIX INVESTOR ALERT by the Former Attorney General of Louisi - WICZ

Mar 10, 2025
pulisher
Mar 10, 2025

Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chimerix, Inc. - Financial Content

Mar 10, 2025
pulisher
Mar 10, 2025

CHIMERIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chimerix, Inc.CMRX - Business Wire

Mar 10, 2025
pulisher
Mar 09, 2025

Why Chimerix, Inc. (CMRX) Soared Last Week - Insider Monkey

Mar 09, 2025
pulisher
Mar 09, 2025

10 Micro-, Small-Cap Firms Were Last Week’s Top Performers - Insider Monkey

Mar 09, 2025
pulisher
Mar 07, 2025

Chimerix Expands Team with Strategic New Hire, Offers 70K Share Options Package - StockTitan

Mar 07, 2025
pulisher
Mar 07, 2025

Chimerix, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 07, 2025

CMRX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Chimerix, Inc. is Fair - Bluefield Daily Telegraph

Mar 07, 2025
pulisher
Mar 07, 2025

CMRX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Chimerix, Inc. is Fair to Shareholders - GlobeNewswire

Mar 07, 2025

Finanzdaten der Chimerix Inc-Aktie (CMRX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.26%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
Kapitalisierung:     |  Volumen (24h):